1. Korean Center for Disease Control and Prevention. Guideline for the control of tuberculosis 2006;Seoul: Korean Center for Disease Control and Prevention.
2. Korean Academy of Tuberculosis and Respiratory Diseases. Guideline for the management of tuberculosis 2005;Seoul: Korean Academy of Tuberculosis and Respiratory Diseases.
3. American Thoracic Society. Center for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-1395.
4. Center for Disease Control and Prevention. Update: Nucleic acid amplification tests for tuberculosis. Morb Mortal Wkly Rep 2000;49:593-594.
5. World Health Organization. Treatment of tuberculosis: Guidelines for national programmes 2003;3rd ed. Geneva: World Health Organization.
6. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Vernon AA, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662.
7. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-548.
8. Rieder H. Interventins for tuberculosis control and elimination. Internationa Union against Tuberculosis and Lung Disease 2002;Paris.
9. World Health Organization. . Guidelines for the programmatic management of drug-resistant tuberculosis 2006;Geneva: World Health Organization.
10. Migliori GB, Raviglione MC, Schaberg T, Davies PD, Zellweger JP, Casali L, et al. Tuberculosis management in Europe. Task Force of the European Respiratory Society, the World Health Organisation and the International Union against Tuberculosis and Lung Disease Europe Region. Eur Respir J 1999;14:978-992.
11. American Thoracic Society. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
12. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25.
13. Shim TS, Koh WJ, Yim JJ, Lew WJ. Diagnosis and treatment of latent tuberculosis infection in Korea. Tuberc respir Dis 2004;57:101-117.
14. Korea Food and Drug Administration. Guideline for the treatment of latent tuberculosis infection in patients using TNF antagonist 2004;Seoul: Korea Food and Drug Administration.
15. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49-55.